Lung Cancer Trial, Not Yet Recruiting NCT07685028 Sponsor: Massachusetts General Hospital Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07685028
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 80 years old or younger.
  • People who are either 40 years of age or older, OR people who are 18 or older and within 10 years of the age at which their youngest relative was diagnosed with lung cancer (for example, if a relative was diagnosed at age 35, the person would need to be at least 25 years old).
  • People who have a family history of lung cancer, meaning they have at least one close relative (parent, sibling, or child) diagnosed with non-small cell or small cell lung cancer, OR at least two more distant relatives (such as a grandparent, blood-related aunt or uncle, grandchild, blood-related niece or nephew, or half-sibling) diagnosed with either type of lung cancer.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have been diagnosed with lung cancer themselves at the time of joining the trial.
  • People who have been diagnosed with a stage IV (advanced) cancer of any type at the time of joining the trial.
  • People who have had any part of a lung surgically removed (note: needle or core lung biopsies do not count as exclusions) at the time of joining the trial.
  • People who have had a chest CT scan within the 12 months before joining the trial.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Allison Chang, MD, Massachusetts General Hospital

Phone: 617-724-4000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 October 2026
Est. completion
31 December 2033

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Sybil's performance in predicting future lung cancer diagnoses

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov